PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 23(5): 504-506 2003
© 2003 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lui, S.
Right arrow Articles by Lo, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lui, S.
Right arrow Articles by Lo, W.
Peritoneal Dialysis International, Vol 23, Issue 5, 504-506
Copyright © 2003 by International Society for Peritoneal Dialysis


Case Reports

Feasibility of reinstitution of CAPD after partial hepatectomy in patients with malignant hepatic tumors

SL Lui, PS Yip, MF Lam, and WK Lo

University Department of Medicine, Tung Wah Hospital, Hong Kong SAR, People's Republic of China. sllui@hkucc.hku.hk

OBJECTIVE: To determine the feasibility of reinstitution of continuous ambulatory peritoneal dialysis (CAPD) in patients with malignant hepatic tumors after partial hepatectomy. DESIGN: Retrospective analysis of 2 CAPD patients. SETTING: Dialysis unit of a university teaching hospital. PATIENTS: Two CAPD patients with malignant hepatic tumors who had undergone partial hepatectomy. MAIN OUTCOME MEASURES: Serum biochemistry, Kt/V, peritoneal equilibration test (PET) results before and after hepatectomy. RESULTS: One patient was able to resume CAPD 4 weeks after partial hepatectomy. The other patient was successfully resumed on CAPD after resting the peritoneum for 3 months following partial hepatectomy. The serum biochemistry, Kt/V, and PET results of the 2 patients did not change significantly before and after partial hepatectomy. CONCLUSIONS: Reinstitution of CAPD after partial hepatectomy in patients with malignant hepatic tumors is feasible.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2003 by Multimed Inc.